MEJLGAARD INVEST ApS: Financial statements 2016
CVR: 10042933
Source: annual report 2016, Danish Business Authority
01/05/2015 – 30/04/2016
MEJLGAARD INVEST ApS (CVR 10042933) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -38,203 and a net result of DKK -298,313 compared with DKK 1,904,471 the year before. Equity in the 2016 report amounted to DKK 10,849,853. The solvency ratio was 77.6%.
- Gross Profit
- DKK -38,203
- Profit/Loss
- DKK -298,313
- Equity
- DKK 10,849,853
- Total Assets
- DKK 13,976,360
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -38K | -298K | 10.8M | - |
| 2015 | - | -26K | 1.9M | 11.2M | 0 |
| 2014 | - | -26K | 257K | 9.4M | 0 |
| 2013 | - | -42K | 1M | 9.3M | 0 |
Official annual report
Find more companies like MEJLGAARD INVEST ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout MEJLGAARD INVEST ApS
MEJLGAARD INVEST ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 1985. The company has been dissolved on 3 September 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company was previously named S.M.J. PHARMA AF 1/10 85 ApS. The company has 1 employee (2023). In 2023, the company reported a gross profit of DKK -35,584 and a net result of DKK 99,498 compared with DKK -493,634 the year before. Equity in the 2023 report amounted to DKK 16,267,957.